{"id":"varenicline-pill","safety":{"commonSideEffects":[{"rate":"30","effect":"Nausea"},{"rate":"20","effect":"Insomnia"},{"rate":"13","effect":"Abnormal dreams"},{"rate":"13","effect":"Headache"},{"rate":"10","effect":"Dizziness"},{"rate":"8","effect":"Constipation"},{"rate":"6","effect":"Flatulence"}]},"_chembl":{"chemblId":"CHEMBL1076903","moleculeType":"Small molecule","molecularWeight":"211.27"},"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"Varenicline binds with high affinity and selectivity to the alpha-4 beta-2 nicotinic receptor subtype in the brain. As a partial agonist, it provides modest dopamine release to reduce withdrawal symptoms while simultaneously blocking nicotine from binding to these receptors, thereby diminishing the reinforcing effects of smoking and reducing the motivation to use tobacco.","oneSentence":"Varenicline is a partial agonist at the alpha-4 beta-2 nicotinic acetylcholine receptor that reduces nicotine cravings and blocks the rewarding effects of nicotine.","_ai_confidence":"high"},"_scrapedAt":"2026-03-28T00:14:52.450Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Smoking cessation in adults"}]},"trialDetails":[{"nctId":"NCT06582888","phase":"EARLY_PHASE1","title":"Advancing VR-based Attentional Bias as a Biomarker for Tobacco Use Disorder","status":"RECRUITING","sponsor":"University of California, San Diego","startDate":"2024-11-19","conditions":"Nicotine Addiction, Craving","enrollment":200},{"nctId":"NCT06832085","phase":"PHASE4","title":"Combination Nicotine Replacement Therapy, Cytisine, or Varenicline for Smoking Cessation","status":"RECRUITING","sponsor":"Ottawa Heart Institute Research Corporation","startDate":"2025-04-30","conditions":"Tobacco","enrollment":150},{"nctId":"NCT04525755","phase":"PHASE1, PHASE2","title":"STARS (Smoking Treatment And Remote Sampling) Study","status":"COMPLETED","sponsor":"Medical University of South Carolina","startDate":"2021-02-08","conditions":"Smoking, Smoking Cessation, Tobacco Smoking","enrollment":652},{"nctId":"NCT02162849","phase":"PHASE4","title":"Reward Sensitivity and Pharmacotherapy for Smoking Cessation","status":"ACTIVE_NOT_RECRUITING","sponsor":"M.D. Anderson Cancer Center","startDate":"2015-12-14","conditions":"Tobacco Use Cessation","enrollment":204},{"nctId":"NCT05703672","phase":"PHASE3","title":"Switching to E-cigarettes in Smokers Not Interested in Quitting","status":"RECRUITING","sponsor":"University of Kansas Medical Center","startDate":"2023-07-17","conditions":"Smoking Reduction","enrollment":500},{"nctId":"NCT06474299","phase":"PHASE4","title":"The Avenues Study: Dual Use Cessation","status":"RECRUITING","sponsor":"University of Wisconsin, Madison","startDate":"2024-09-24","conditions":"Smoking Cessation, Electronic Cigarette Use","enrollment":500},{"nctId":"NCT04199117","phase":"PHASE4","title":"Health Systems Reach Interventions Project","status":"COMPLETED","sponsor":"University of Wisconsin, Madison","startDate":"2020-03-11","conditions":"Smoking, Cigarette, Smoking Cessation","enrollment":210},{"nctId":"NCT04188873","phase":"PHASE4","title":"Cessation Screening Project","status":"COMPLETED","sponsor":"University of Wisconsin, Madison","startDate":"2020-12-10","conditions":"Nicotine Dependence","enrollment":529},{"nctId":"NCT06688539","phase":"PHASE4","title":"E-cigarette Cessation in Adults Who Co-use Cannabis","status":"RECRUITING","sponsor":"Medical University of South Carolina","startDate":"2025-02-19","conditions":"Nicotine Dependence, Tobacco Use Disorder","enrollment":105},{"nctId":"NCT06679374","phase":"PHASE2","title":"Reducing Falls With Varenicline in Hypocholinergic Parkinson Disease","status":"RECRUITING","sponsor":"Vikas Kotagal","startDate":"2025-04-09","conditions":"Parkinson Disease","enrollment":102},{"nctId":"NCT05541497","phase":"PHASE2","title":"Varenicline for Treatment of E-cigarette Dependence","status":"COMPLETED","sponsor":"Yale University","startDate":"2022-11-04","conditions":"Smoking Cessation","enrollment":40},{"nctId":"NCT01511614","phase":"NA","title":"Nicotine Withdrawal Symptoms and Smoking Relapse","status":"COMPLETED","sponsor":"National Institute on Drug Abuse (NIDA)","startDate":"2013-05-20","conditions":"Nicotine Dependence","enrollment":112},{"nctId":"NCT03980561","phase":"PHASE2","title":"UH3 Varenicline for Cannabis Use Disorder","status":"COMPLETED","sponsor":"Medical University of South Carolina","startDate":"2020-01-31","conditions":"Cannabis Use Disorder","enrollment":174},{"nctId":"NCT01413516","phase":"PHASE2","title":"Varenicline In-Patient Study","status":"COMPLETED","sponsor":"Stanford University","startDate":"2011-08","conditions":"Smoking Cessation","enrollment":17},{"nctId":"NCT04188106","phase":"PHASE4","title":"Efficacy and Tolerability of Combination Varenicline With Hydroxyzine as a Potential Smoking Cessation Treatment","status":"COMPLETED","sponsor":"Rose Research Center, LLC","startDate":"2019-06-17","conditions":"Smoking Cessation, Stress, Sleep Disturbance","enrollment":26},{"nctId":"NCT03176784","phase":"PHASE4","title":"UW Quitting Using Intensive Treatment Study (QUITS)","status":"COMPLETED","sponsor":"University of Wisconsin, Madison","startDate":"2017-11-11","conditions":"Tobacco Dependence","enrollment":1251},{"nctId":"NCT01341080","phase":"PHASE2","title":"Varenicline for Gait and Balance Impairment in Parkinson Disease","status":"COMPLETED","sponsor":"Rush University Medical Center","startDate":"2010-12-28","conditions":"Parkinson Disease","enrollment":40},{"nctId":"NCT00554840","phase":"PHASE2","title":"Comparison of Varenicline and Placebo for Smoking Cessation in Schizophrenia","status":"COMPLETED","sponsor":"University of Maryland, Baltimore","startDate":"2007-11","conditions":"Cigarette Smoking, Schizophrenia","enrollment":16},{"nctId":"NCT02859142","phase":"PHASE4","title":"Varenicline Augmentation of Patch Outcomes in Heavy Drinkers' Smoking Cessation","status":"COMPLETED","sponsor":"University of Chicago","startDate":"2018-03-29","conditions":"Smoking Cessation, Alcohol Drinking","enrollment":122},{"nctId":"NCT01027754","phase":"PHASE4","title":"Smoking Cessation Treatment for Methadone Maintenance Patients","status":"COMPLETED","sponsor":"Albert Einstein College of Medicine","startDate":"2009-08","conditions":"Smoking Cessation, Substance-Related Disorders","enrollment":112},{"nctId":"NCT02797587","phase":"PHASE2, PHASE3","title":"Studying Partial-agonists for Ethanol and Tobacco Elimination in Russians With HIV (St PETER HIV)","status":"COMPLETED","sponsor":"Boston Medical Center","startDate":"2017-07-19","conditions":"HIV Infection, Alcohol Use, Smoking","enrollment":400},{"nctId":"NCT03742154","phase":"EARLY_PHASE1","title":"Hollings Cancer Center Varenicline Sampling Study","status":"COMPLETED","sponsor":"Medical University of South Carolina","startDate":"2018-12-03","conditions":"Smoking, Smoking Cessation, Smoking, Tobacco","enrollment":99},{"nctId":"NCT02351167","phase":"PHASE4","title":"Genetically Informed Smoking Cessation Trial","status":"COMPLETED","sponsor":"Washington University School of Medicine","startDate":"2015-05-20","conditions":"Smoking Cessation","enrollment":822},{"nctId":"NCT01553084","phase":"PHASE4","title":"A Comparative Effectiveness & Long Term Health Study in Wisconsin Smokers","status":"COMPLETED","sponsor":"University of Wisconsin, Madison","startDate":"2012-05","conditions":"Smoking Cessation, Smoking, Nicotine Dependence","enrollment":1086},{"nctId":"NCT02854800","phase":"PHASE2, PHASE3","title":"Smoking Cessation & Opioid Dependence Treatment Integration","status":"COMPLETED","sponsor":"West Virginia University","startDate":"2016-07-08","conditions":"Smoking Cessation, Opioid Related Disorders","enrollment":74},{"nctId":"NCT02360631","phase":"PHASE4","title":"Advancing Tobacco Use Treatment for African American Smokers","status":"COMPLETED","sponsor":"Lisa Sanderson Cox, PhD","startDate":"2015-07-29","conditions":"Smoking Cessation","enrollment":500},{"nctId":"NCT00567320","phase":"NA","title":"Efficacy of Varenicline in Methadone-Stabilized Cocaine Users","status":"COMPLETED","sponsor":"Yale University","startDate":"2007-03","conditions":"Cocaine Dependence, Nicotine Dependence","enrollment":31},{"nctId":"NCT01553136","phase":"PHASE2","title":"Varenicline Treatment of Alcohol Dependence in Smokers","status":"COMPLETED","sponsor":"Yale University","startDate":"2012-09","conditions":"Alcoholism, Alcohol Abuse, Smoking","enrollment":131},{"nctId":"NCT01756885","phase":"PHASE3","title":"Extended Varenicline Treatment for Smoking Among Cancer Patients","status":"COMPLETED","sponsor":"University of Pennsylvania","startDate":"2013-01","conditions":"Nicotine Dependence","enrollment":207},{"nctId":"NCT00794573","phase":"PHASE3","title":"Evaluation of Varenicline (Champix) in Smoking Cessation for Patients Post-Acute Coronary Syndrome (EVITA) Trial","status":"COMPLETED","sponsor":"Mark Eisenberg","startDate":"2009-09","conditions":"Acute Coronary Syndrome","enrollment":302},{"nctId":"NCT03553173","phase":"NA","title":"So-Lo-Mo Intervention Applied to the Smoking Cessation Process","status":"COMPLETED","sponsor":"Fundación Pública Andaluza para la gestión de la Investigación en Sevilla","startDate":"2016-10-24","conditions":"Smoking Cessation, Health Behavior, Lifestyle-related Condition","enrollment":240},{"nctId":"NCT00756275","phase":"NA","title":"Varenicline and Motivational Advice for Smokers With Substance Use Disorders","status":"COMPLETED","sponsor":"Brown University","startDate":"2009-01","conditions":"Smoking Cessation, Nicotine Dependence","enrollment":158},{"nctId":"NCT02488889","phase":"PHASE4","title":"Effects of Varenicline in Heavy Drinking Smokers","status":"WITHDRAWN","sponsor":"University of California, Los Angeles","startDate":"2015-08","conditions":"Cigarette Smoking, Alcohol Consumption","enrollment":""},{"nctId":"NCT02635919","phase":"NA","title":"Stage Ib Trial of mSMART for Smoking Cessation Medication Adherence","status":"UNKNOWN","sponsor":"Duke University","startDate":"2016-04","conditions":"Nicotine Dependence","enrollment":60},{"nctId":"NCT00713479","phase":"PHASE1","title":"An Assessment of the Safety of Varenicline in Methamphetamine-dependent Volunteers","status":"COMPLETED","sponsor":"University of California, Los Angeles","startDate":"2008-07","conditions":"Methamphetamine Addiction, Crystal Meth Addiction, Amphetamine Addiction","enrollment":8},{"nctId":"NCT01639560","phase":"PHASE4","title":"Varenicline for Light Smokers","status":"COMPLETED","sponsor":"Mayo Clinic","startDate":"2013-01","conditions":"Smoking","enrollment":93},{"nctId":"NCT01347112","phase":"PHASE2, PHASE3","title":"Varenicline Treatment for Active Alcoholic Smokers","status":"COMPLETED","sponsor":"Mayo Clinic","startDate":"2011-06","conditions":"Smoking, Tobacco Dependence, Alcohol Dependence","enrollment":33},{"nctId":"NCT01365819","phase":"PHASE2","title":"Varenicline for Methamphetamine Dependence","status":"COMPLETED","sponsor":"University of California, Los Angeles","startDate":"2012-02","conditions":"Methamphetamine Dependence, Substance Abuse, Methamphetamine Abuse","enrollment":52},{"nctId":"NCT00621777","phase":"PHASE4","title":"A Study of Varenicline for Prevention of Relapse to Smoking in Patients With Schizophrenia or Bipolar Disorder","status":"COMPLETED","sponsor":"Massachusetts General Hospital","startDate":"2008-02","conditions":"Schizophrenia, Schizoaffective Disorder, Bipolar Disorder","enrollment":247},{"nctId":"NCT01524627","phase":"PHASE2","title":"Effects of Varenicline on Smoking Reminders","status":"COMPLETED","sponsor":"University of Pennsylvania","startDate":"2011-12","conditions":"Nicotine Dependence","enrollment":124},{"nctId":"NCT01308736","phase":"NA","title":"Varenicline-Aided Cigarette Reduction in Smokers Not Ready to Quit","status":"COMPLETED","sponsor":"Rutgers, The State University of New Jersey","startDate":"2011-01","conditions":"Tobacco Use Disorder","enrollment":73},{"nctId":"NCT01243203","phase":"NA","title":"Smoking Cessation Program in the Preadmission Clinic: The Use of a Teachable Moment","status":"COMPLETED","sponsor":"University Health Network, Toronto","startDate":"2007-11","conditions":"Smoking","enrollment":300},{"nctId":"NCT01850953","phase":"PHASE4","title":"Effects of Varenicline on Smoking Lapse in Smokers With and Without Schizophrenia","status":"COMPLETED","sponsor":"Centre for Addiction and Mental Health","startDate":"2013-06","conditions":"Craving, Smoking, Schizophrenia","enrollment":28},{"nctId":"NCT01772641","phase":"PHASE4","title":"A Smoking Intervention Study Using Scheduled Gradual Reduction With Varenicline to Help With Cessation","status":"TERMINATED","sponsor":"Icahn School of Medicine at Mount Sinai","startDate":"2012-12","conditions":"Nicotine Addiction","enrollment":32},{"nctId":"NCT01314001","phase":"PHASE3","title":"Pharmacogenetics of Nicotine Addiction Treatment","status":"COMPLETED","sponsor":"University of Pennsylvania","startDate":"2010-12","conditions":"Nicotine Addiction","enrollment":1246},{"nctId":"NCT01532232","phase":"","title":"Tobacco Dependence in Breast Cancer Patients Trial of Varenicline (Chantix)","status":"TERMINATED","sponsor":"Memorial Sloan Kettering Cancer Center","startDate":"2012-02","conditions":"Breast Cancer, Tobacco Dependence","enrollment":7},{"nctId":"NCT01934023","phase":"PHASE2","title":"Effects of Varenicline on Plasticity in Schizophrenia","status":"COMPLETED","sponsor":"Centre for Addiction and Mental Health","startDate":"2013-09","conditions":"Schizophrenia","enrollment":24},{"nctId":"NCT00781755","phase":"PHASE4","title":"Treating Schizophrenic Smokers: Effects on Craving, Cues and Withdrawal","status":"WITHDRAWN","sponsor":"VA Boston Healthcare System","startDate":"","conditions":"Tobacco Use Disorder","enrollment":""},{"nctId":"NCT00948155","phase":"PHASE4","title":"Measuring Smoking Behaviors While Using Varenicline","status":"COMPLETED","sponsor":"University of Pennsylvania","startDate":"2009-01","conditions":"Nicotine Dependence","enrollment":48},{"nctId":"NCT00606892","phase":"NA","title":"Varenicline and Nicotine Interactions in Humans (VA)","status":"COMPLETED","sponsor":"Yale University","startDate":"2007-08","conditions":"Smoking Cessation","enrollment":37},{"nctId":"NCT01146613","phase":"PHASE2","title":"Varenicline for Alcohol Dependence","status":"COMPLETED","sponsor":"National Institute on Alcohol Abuse and Alcoholism (NIAAA)","startDate":"2011-02","conditions":"Alcoholism","enrollment":200},{"nctId":"NCT00918307","phase":"PHASE3","title":"Efficacy and Safety of Varenicline Among HIV-infected Patients","status":"COMPLETED","sponsor":"ANRS, Emerging Infectious Diseases","startDate":"2009-10","conditions":"HIV Infections, Tobacco Dependence","enrollment":248},{"nctId":"NCT01111149","phase":"PHASE2","title":"Varenicline and Smoking Cessation in Schizophrenia","status":"COMPLETED","sponsor":"University of Minnesota","startDate":"2009-12","conditions":"Schizophrenia, Smoking Cessation","enrollment":24},{"nctId":"NCT00935818","phase":"PHASE2, PHASE3","title":"Varenicline and Bupropion for Smoking Cessation","status":"COMPLETED","sponsor":"Mayo Clinic","startDate":"2009-09","conditions":"Smoking","enrollment":506},{"nctId":"NCT01571167","phase":"PHASE1","title":"Varenicline as a Treatment for Methamphetamine Dependence","status":"COMPLETED","sponsor":"Baylor College of Medicine","startDate":"2011-01","conditions":"Methamphetamine Dependence, Methamphetamine Abuse, Substance Abuse","enrollment":17},{"nctId":"NCT01011829","phase":"PHASE2","title":"Varenicline vs Placebo for the Treatment of Methamphetamine Dependence","status":"COMPLETED","sponsor":"University of California, Los Angeles","startDate":"2009-11","conditions":"Methamphetamine Dependence, Substance Abuse, Methamphetamine Abuse","enrollment":20},{"nctId":"NCT00733967","phase":"PHASE1","title":"Varenicline-Methamphetamine Interaction Study (2008)","status":"WITHDRAWN","sponsor":"Baylor College of Medicine","startDate":"2008-01","conditions":"Methamphetamine Dependence, Substance Abuse, Methamphetamine Abuse","enrollment":""},{"nctId":"NCT00602927","phase":"NA","title":"Effects of Varenicline on Brain Activity During Nicotine Abstinence","status":"COMPLETED","sponsor":"University of Pennsylvania","startDate":"2007-11","conditions":"Nicotine Dependence","enrollment":38},{"nctId":"NCT00948649","phase":"PHASE4","title":"Effects of Chantix on Relapse Prevention for Smoking Cessation","status":"COMPLETED","sponsor":"University of Pennsylvania","startDate":"2006-09","conditions":"Nicotine Dependence","enrollment":62},{"nctId":"NCT01170338","phase":"PHASE4","title":"Safety and Efficacy of the Novel Selective Nicotinic Receptor Partial Agonist, CHANTIX (Varenicline) in Patients With Acute Coronary Syndrome","status":"UNKNOWN","sponsor":"Newark Beth Israel Medical Center","startDate":"2008-01","conditions":"Smoking, Acute Coronary Syndrome","enrollment":100},{"nctId":"NCT00937508","phase":"PHASE4","title":"Smoking Cessation Program in the Preadmission Clinic","status":"UNKNOWN","sponsor":"University Health Network, Toronto","startDate":"2008-06","conditions":"Smoking","enrollment":290}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":24,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":["Chantix","Varenicline"],"phase":"marketed","status":"active","brandName":"Varenicline Pill","genericName":"Varenicline Pill","companyName":"National Institute on Drug Abuse (NIDA)","companyId":"national-institute-on-drug-abuse-nida","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Varenicline is a partial agonist at the alpha-4 beta-2 nicotinic acetylcholine receptor that reduces nicotine cravings and blocks the rewarding effects of nicotine. Used for Smoking cessation in adults.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":6,"withResults":3},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}